Novozymes A/S banner

Novozymes A/S
CSE:NSIS B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NSIS B
Watchlist
Price: 382.5 DKK 1.19% Market Closed
Market Cap: kr158.6B

EV/GP

17.4
Current
No historical data
Comparison unavailable

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
17.4
=
Enterprise Value
kr169B
/
Gross Profit
kr9.7B

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
17.4
=
Enterprise Value
kr169B
/
Gross Profit
kr9.7B

Valuation Scenarios

Novozymes A/S is trading above its 3-year average

If EV/GP returns to its 3-Year Average (17.4), the stock would be worth kr382.5 (0% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-81%
Maximum Upside
No Upside Scenarios
Average Downside
20%
Scenario EV/GP Value Implied Price Upside/Downside
Current Multiple 17.4 kr382.5
0%
3-Year Average 17.4 kr382.5
0%
5-Year Average 17.4 kr382.5
0%
Industry Average 17.4 kr382.5
0%
Country Average 3.3 kr72.9
-81%

Forward EV/GP
Today’s price vs future gross profit

Not enough data available to calculate forward EV/GP

Peer Comparison

All Multiples
EV/GP
P/E
All Countries
Close
Market Cap EV/GP P/E
DK
Novozymes A/S
CSE:NSIS B
165.6B DKK 17.4 54.8
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
13.5T JPY 13.6 28.4
US
Sherwin-Williams Co
NYSE:SHW
79.7B USD 7.8 31
US
Ecolab Inc
NYSE:ECL
73.5B USD 11.2 35.4
JP
Yasuhara Chemical Co Ltd
TSE:4957
10.8T JPY 3.1 10.5
CN
Wanhua Chemical Group Co Ltd
SSE:600309
280.3B CNY 12.7 21.3
CH
Givaudan SA
SIX:GIVN
25.7B CHF 8.9 23.9
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.3T INR 15.2 60.8
US
PPG Industries Inc
NYSE:PPG
24.2B USD 4.3 15.4
CH
Sika AG
F:SIKA
19.9B EUR 3.5 17.5
US
Albemarle Corp
NYSE:ALB
23.2B USD 36.7 -34.2
P/E Multiple
Earnings Growth PEG
DK
Novozymes A/S
CSE:NSIS B
Average P/E: 29.9
54.8
N/A N/A
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
28.4
N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
31
14%
2.2
US
Ecolab Inc
NYSE:ECL
35.4
14%
2.5
JP
Y
Yasuhara Chemical Co Ltd
TSE:4957
10.5
N/A N/A
CN
Wanhua Chemical Group Co Ltd
SSE:600309
21.3
10%
2.1
CH
Givaudan SA
SIX:GIVN
23.9
6%
4
IN
Asian Paints Ltd
NSE:ASIANPAINT
60.8
15%
4.1
US
PPG Industries Inc
NYSE:PPG
15.4
10%
1.5
CH
Sika AG
F:SIKA
17.5
8%
2.2
US
Albemarle Corp
NYSE:ALB
Negative Multiple: -34.2 N/A N/A

Market Distribution

Higher than 91% of companies in Denmark
Percentile
91st
Based on 336 companies
91st percentile
16.7
Low
0.1 — 1.8
Typical Range
1.8 — 6.4
High
6.4 —
Distribution Statistics
Denmark
Min 0.1
30th Percentile 1.8
Median 3.3
70th Percentile 6.4
Max 57.4

Novozymes A/S
Glance View

Market Cap
158.6B DKK
Industry
Chemicals

Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly. The company’s extensive portfolio of enzymes transforms processes across a diverse array of industries, including agriculture, food and beverages, household care, and bioenergy. By engineering microorganisms to optimize yield and reduce waste, Novozymes provides solutions that both enhance product performance and support environmental goals. Revenue generation for Novozymes predominantly stems from its ability to innovate and provide proprietary solutions that businesses around the world rely on to gain a competitive edge. While enzymes in detergents simplify stain removal and enable energy-efficient washing at lower temperatures, in agriculture, Novozymes' biological solutions enhance crop yield by fostering nutrient absorption and pest resilience. This vast spectrum of applications showcases the company's deep integration into its clients' production processes, creating a stable demand. Novozymes capitalizes on its research and development prowess, ensuring a continuous flow of advanced, tailor-made bio-solutions, thereby securing long-term partnerships and a sustainable revenue stream from its global market presence.

NSIS B Intrinsic Value
Not Available
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett